Table 3

Adverse drug reactions (ADRs) from RCTs and prospective cohort studies requiring specific measurements

Adverse effectsNo. of patients with ADRsNo. of studies reporting ADRNo. of studies looking for ADRTotal no. of patientsIncidence (%)
Increased blood pressure1444636939
HPA axis suppression43445381
Weight gain21227528
Decreased bone mineralisation111111
  • HPA, hypothalamic–pituitary–adrenal; RCT, randomised controlled trial.